BRAINSWAY LTD/S (BWAY) Research Coverage Started at CIBC

Equities research analysts at CIBC began coverage on shares of BRAINSWAY LTD/S (NASDAQ:BWAY) in a research report issued to clients and investors on Monday, FirstToMarketsRatingsTable reports. The firm set an “outperform” rating on the stock.

BWAY has been the subject of a number of other reports. Cantor Fitzgerald assumed coverage on shares of BRAINSWAY LTD/S in a research note on Monday. They set an “overweight” rating and a $17.00 price objective for the company. LADENBURG THALM/SH SH assumed coverage on shares of BRAINSWAY LTD/S in a research note on Monday. They set a “buy” rating and a $19.00 price objective for the company. Raymond James assumed coverage on shares of BRAINSWAY LTD/S in a research note on Monday. They set an “outperform” rating and a $14.00 price objective for the company. Finally, Oppenheimer assumed coverage on shares of BRAINSWAY LTD/S in a research note on Monday. They set an “outperform” rating and a $17.00 price objective for the company. Five investment analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of $16.75.

BWAY stock opened at $10.71 on Monday. BRAINSWAY LTD/S has a one year low of $10.30 and a one year high of $12.39.



BRAINSWAY LTD/S Company Profile

Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.

See Also: Insider Trading

Analyst Recommendations for BRAINSWAY LTD/S (NASDAQ:BWAY)

Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.